Viewing Study NCT02722057


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2025-12-29 @ 2:32 AM
Study NCT ID: NCT02722057
Status: COMPLETED
Last Update Posted: 2020-02-05
First Post: 2016-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module